Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

Bristol Myers Squibb Co.’s treatment for schizophrenia failed in a study designed to expand its use, denting the company’s ...

Telangana Anti Narcotics Bureau apprehended Ezeonyili Franklin Uchenna, a Nigerian drug supplier, in Hyderabad after he had ...

BPaL/M is a six-month all-oral regimen recommended by the World Health Organization (WHO) to treat most forms of ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

Optimize your acne treatment approach with these key tips on using antibiotics properly, combining therapies, and ensuring ...